Canon Medical Systems Debuts New CT Systems at RSNA Conference
The Aquilion ONE/Insight Edition and Aquilion Serve SP computed tomography (CT) systems reportedly offer enhanced deep learning reconstruction and intuitive workflow efficiencies.
Combining imaging advances with the promise of innovative workflow efficiencies, Canon Medical Systems is showcasing the new computed tomography (CT) systems Aquilion ONE/Insight Edition and Aquilion Serve SP this week at the annual Radiological Society of North America (RSNA) conference this week in Chicago.
For the Aquilion ONE/Insight Edition, the company says key benefits include enhanced image resolution with deep learning reconstruction technology, the capability to perform full-body scans in seconds and a compact, air-cooled design that can be accommodated in standard CT rooms. The system’s INSTINX automation also allows for a 40 percent reduction in workflow steps, according to Canon Medical Systems.
In addition to deep learning reconstruction capabilities, the Aquilion Serve SP system enables scanning of multiple areas with one breath hold and one injection. Canon Medical Systems adds that the device’s Anatomic Landmark Detection offers a 97 percent accuracy in scan range planning.
“With … the Aquilion ONE / INSIGHT Edition and Aquilion Serve SP, we are simplifying and streamlining CT workflow, making the scan experience for more efficient for patients and operators alike,” noted Naoki Sugihara, a vice president and general manager of the CT Systems Division at Canon Medical Systems.
Canon Medical Systems noted that both CT systems are pending 510(k) clearance from the Food and Drug Administration (FDA).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
